** CREDENTIALED PRESS ONLY **
A media briefing on new safety controlsfor long-acting beta agonists, medications used to treat asthma
--Janet Woodcock, M.D., director, Center for Drug Evaluation and Research (CDER), FDA
--Gerald Dal Pan, M.D., director, Office of Surveillance and Epidemiology, CDER, FDA
--Badrul Chowdhury, M.D., director, Division of Pulmonary and Allergy Products, Office of Drug Evaluation II, CDER, FDA
--Sally Seymour, M.D., deputy director for safety, Division of Pulmonary and Allergy Products, Office of Drug Evaluation II, CDER
Thurs., Feb. 18, 2010, 1:15 p.m. EST
Reporters may participate in a listen-only mode by dialing 888-455-0031 or for international reporters, 1-312-470-0068. The password for all callers is "FDA." A replay of the briefing will be available until Feb. 25 by calling 888-562-2793 or for international reporters, 1-402-998-1450.
CONTACT: Karen Riley, 301-796-4674 (office), email@example.com, or Erica Jefferson, 301-796-4988, firstname.lastname@example.org, both of FDA
/PRNewswire-USNewswire -- Feb. 18/
SOURCE U.S. Food and Drug Administration
Subscribe to our Free Newsletters!
HELLP syndrome is a rare but serious complication that affects pregnant women. If detected on time, ...
Discectomy is a surgical procedure in which a herniated (bulged) disc that compresses the nerves of ...
Parotidectomy is a surgery to remove a part of or the entire parotid salivary gland, on the side of ...View All